Edesa Biotech Inc (EDSA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access EDSA Annual Balance Sheets →
Balance sheet performance over multiple periods helps investors evaluate the financial resilience of Edesa Biotech Inc.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent10.30
Cash & Short-term Investments10.00
Accounts receivable0.23
Other Current Assets0.03
Prepaid Expense And Other Assets Current0.22
Total Current Assets10.78
Intangible Assets1.90
Deposits Assets, Noncurrent AS0.04
Tax Assets, Noncurrent0.00
Other Assets, Noncurrent0.00
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents10.00
Total Assets12.72
Liabilities
Accounts Payable and Accrued Liabilities, Current LI3.91
Other Liabilities, Current0.00
Total Current Liabilities3.91
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent0.00
Total Liabilities3.91
Stockholders' Equity
Common Stock Value62.42
Additional Paid In Capital Common Stock16.04
Retained Earnings / Accumulated Deficit-77.90
Accumulated Other Comprehensive Income-0.16
Other Equity-0.16
Common Stockholder's Equity8.81
Preferred Stockholder's Equity0.00
Total Stockholder's Equity8.81
Liabilities & Stockholder's Equity12.72
4 historic quarters locked

Sign in to unlock the full Edesa Biotech Inc balance sheet history.

About Edesa Biotech Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001171843-26-005502

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.